These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2994117)

  • 1. The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.
    Chesher GB; Jackson DM
    Pharmacol Biochem Behav; 1985 Jul; 23(1):13-5. PubMed ID: 2994117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
    Hine B; Torrelio M; Gershon S
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
    Thornton C; Dickson KE; Carty DR; Ashpole NM; Willett KL
    Epilepsy Behav; 2020 Sep; 110():107152. PubMed ID: 32585475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
    Zaluzny SG; Chesher GB; Jackson DM; Malor R
    Psychopharmacology (Berl); 1979 Mar; 61(2):207-16. PubMed ID: 86997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between cannabidiol and delta9-THC during abstinence in morphine-dependent rats.
    Hine B; Torrelio M; Gershon S
    Life Sci; 1975 Sep; 17(6):851-7. PubMed ID: 1238886
    [No Abstract]   [Full Text] [Related]  

  • 8. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
    Alozie SO; Martin BR; Harris LS; Dewey WL
    Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
    Hiltunen AJ; Järbe TU; Kamkar MR; Archer T
    Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
    Murphy LL; Steger RW; Smith MS; Bartke A
    Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
    Niesink RJ; Rigter S; Koeter MW; Brunt TM
    Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids in glaucoma: a primary screening procedure.
    Elsohly MA; Harland E; Murphy JC; Wirth P; Waller CW
    J Clin Pharmacol; 1981; 21(S1):472S-478S. PubMed ID: 6271842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
    Dalterio S; Steger R; Mayfield D; Bartke A
    Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite.
    Kroner GM; Johnson-Davis KL; Doyle K; McMillin GA
    J Appl Lab Med; 2020 May; 5(3):569-574. PubMed ID: 32445358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice.
    Chesher GB; Dahl CJ; Everingham M; Jackson DM; Marchant-Williams H; Starmer GA
    Br J Pharmacol; 1973 Dec; 49(4):588-94. PubMed ID: 4788032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing human hair for Cannabis. III. rapid screening procedure for the simultaneous identification of delta 9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Cirimele V; Sachs H; Kintz P; Mangin P
    J Anal Toxicol; 1996; 20(1):13-6. PubMed ID: 8837945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of cannabinoids with bovine serum albumin.
    Haque SJ; Poddar MK
    Biosci Rep; 1984 Mar; 4(3):239-43. PubMed ID: 6326885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Strategies for Rare Cannabinoids Derived from
    Nguyen GN; Jordan EN; Kayser O
    J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.